Epidemiology of alveolar echinococcosis with particular reference to China and Europe

D. A. VUITTON a1c1, H. ZHOU a1a2p1, S. BRESSON-HADNI a1, Q. WANG a1a3, M. PIARROUX a1, F. RAOUL a1 and P. GIRAUDOUX a1
a1 WHO Collaborating Centre for the Prevention and Treatment of Alveolar Echinococcosis, SERF and LBE Usc INRA research units, Université de Franche-Comté, 25030 – Besançon, France
a2 Xinjiang Medical University, 83000 Urumqi, Xinjiang, PR China
a3 Sichuan Institute of Parasitic Diseases, Chengdu, Sichuan, PR China

Article author query
vuitton d   [PubMed][Google Scholar] 
zhou h   [PubMed][Google Scholar] 
bresson-hadni s   [PubMed][Google Scholar] 
wang q   [PubMed][Google Scholar] 
piarroux m   [PubMed][Google Scholar] 
raoul f   [PubMed][Google Scholar] 
giraudoux p   [PubMed][Google Scholar] 


Human alveolar echinococcosis (AE), caused by the metacestode of the fox tapeworm Echinococcus multilocularis, is the most pathogenic zoonosis in temperate and arctic regions of the northern hemisphere. Prospective collection of human cases in some areas and mass screenings using ultrasound imaging and confirmation with serological techniques have markedly improved our knowledge of the epidemiology of the disease in humans during the past two decades. Transmission occurs when eggs of the tapeworm, excreted by the final hosts (usually foxes but also dogs, wolves and cats), are ingested accidentally by humans or during normal feeding by a variety of rodents and small lagomorphs. However, the species of host animals differ according to regional changes in mammalian fauna. This review mostly focuses on epidemiology of alveolar echinococcosis in those parts of the world where new and more accurate epidemiological data are now available, i.e. China and Europe, as well as on new epidemiological trends that can be suspected from recent case reports and/or from recent changes in animal epidemiology of E. multilocularis infection. The People's Republic of China (PRC) is a newly recognized focus on AE in Asia. Human AE cases were firstly recognized in Xinjiang Uygur Autonomous Region and Qinghai Provinces at the end of 1950s and infected animals were first reported from Ningxia in central China and north-east of Inner Mongolia in the 1980s. E. multilocularis (and human cases of AE) appears to occur in three areas: (1) Northeastern China (northeast focus): including Inner Mongolia Autonomous region and Heliongjiang Province (2) Central China (central focus): including Gansu Province, Ningxia Hui Autonomous Region, Sichuan Province, Qinghai Province and Tibet Autonomous Region and (3) Northwestern China: including Xinjiang Uygur Autonomous Region, bordered with Mongolia, Russia, Kazakhstan and Kyrgyzstan. The highest prevalence of the disease, up to 15 per cent of the population in some villages, is reached in China. In Europe, data from the European Echinococcosis Registry (EurEchinoReg: 1982–2000) show 53 autochthonous cases of AE in Austria, 3 in Belgium, 235 in France, 126 in Germany, 1 in Greece, and 112 in Switzerland, and 15 ‘imported’ cases, especially from central Asia; 14 cases were collected in Poland, a country not previously considered endemic for AE. Improved diagnostic technology, as well as a real increase in the infection rate and an extension to new areas, can explain that more than 500 cases have been reported for these 2 decades while less than 900 cases were published for the previous 7 decades. New epidemiological trends are related to an unprecedented increase in the fox population in Europe, to the unexpected development of urban foxes in Japan and in Europe, and to changes in the environmental situation in many countries worldwide due to climatic or anthropic factors which might influence the host–predator relationship in the animal reservoir and/or the behavioural characteristics of the populations in the endemic areas.

Key Words: Alveolar echinococcosis; Echinococcus multilocularis; epidemiology; animal hosts; risk factors; geography.

c1 Tel and Fax: 33 3 81 66 55 70. E-mail:
p1 Present address: Public Health College, Guanxi Medical University, Nanning city, PR China.